Cardia, Inc.

Biosense Webster Inc. – Johnson & Johnson 's heart-rhythm device business – is already the exclusive distributor of Coherex Medical Inc. 's WaveCrest left atrial appendage occlusion system out

In the market for left atrial appendage closure (LAAC) devices, Boston Scientific Corp. 's WATCHMAN device currently enjoys a monopoly in the US as the only endocardial device on the market. Othe

Since the FDA approval of Boston Scientific Corp. 's (BSX) WATCHMAN device in March, the market for transcatheter left atrial appendage closure (LAAC) devices has reached a tipping point. After a

by Eric Eggers The PFO (patent foramen ovale) closure market has continued to mature in 2009, with the latest round of developments reported at the 2009 Transcatheter Cardiovascular Therapeutics (TCT)